The process for advanced cell therapy for cancer patients takes place within a highly controlled, isolated unit at the University Clinical Center (UCC) Ljubljana. According to Matjaž Sever, deputy head of the Clinical Department of Hematology, the environment is maintained with filtered air to prevent potential airborne pathogens, such as spores, from entering the facility and causing infection. This specialized center facilitates a complex procedure involving the patient’s own immune cells.
The process begins by collecting lymphocytes from each patient. These cells are then transported to the Institute of Microbiology and Immunology for specialized transformation. Here, the cells are engineered into a therapeutic agent using viral vectors, a method that essentially teaches the patient’s own immune system how to identify and attack malignant cells.
The goal of this intensive treatment is to empower the patient’s natural defenses to combat the cancer. The entire cycle of cell preparation and transformation lasts for five weeks. The facility is equipped to handle these delicate biological processes, ensuring the safety and efficacy required for treating serious hematological conditions.
This sophisticated setting is where the foundational work for advanced cancer treatment is performed, utilizing the patient’s biology to create a targeted drug.
Topics: #center #where #cancer
